20 Gy versus 44 Gy supplemental beam radiation with Pd-103 prostate brachytherapy: Preliminary biochemical outcomes from a prospective randomized multi-center trial

Radiotherapy and Oncology

Volumn 75, Issue 3, 2005, Pages 307-310

  Wallner, Kent ^a,b,c   Merrick, Gregory ^d   True, Lawrence ^e   Sherertz, Tracey ^a   Sutlief, Steven ^a,b   Cavanagh, William ^f   Butler, Wayne ^d  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c CENTER FOR HEALTH STUDIES   (United States)

^d WHEELING HOSPITAL   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f NONE

Author keywords

Brachytherapy; Prostatic carcinoma

Indexed keywords

LEAD; PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BIOCHEMISTRY; BRACHYTHERAPY; CANCER GROWTH; CANCER STAGING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEPHROBLASTOMA; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CARCINOMA; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL;

AGED; BRACHYTHERAPY; HUMANS; MALE; MIDDLE AGED; PALLADIUM; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOISOTOPES; RADIOTHERAPY DOSAGE;

EID: 22444442487     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2005.03.019     Document Type: Article

References (22)

1. B.J. Davis, T.M. Pisansky, and T.M. Wilson The radial distance of extraprostatic extension of prostate carcinoma: implications for prostate brachytherapy Cancer 85 1999 2630 2637
2. C. Sohayda, P.A. Kupelian, J.S. Levin, and E.A. Klein Extent of extracapsular extension in localized prostate cancer Urology 55 2000 382 386
3. L. Kestin, N. Goldstein, F. Vicini, D. Yan, H. Korman, and A. Martinez Treatment of prostate cancer with radiotherapy: should the entire seminal vesicles be included in the clinical target volume? Int J Radiat Oncol Biol Phys 54 2002 686 697
4. G.S. Merrick, W.M. Butler, K.E. Wallner, L.R. Burden, and J.E. Dougherty Extracapsular dose distribution following permanent prostate brachytherapy Am J Clin Oncol 26 2003 178 189
5. G. Merrick, W. Butler, J.H. Lief, R.W. Galbreath, and E. Adamovich Biochemical outcome for hormone-naive intermediate-risk prostate cancer managed with permanent interstitial brachytherapy and supplemental external beam radiation Brachytherapy 1 2002 95 101
6. J. Sylvester, J. Blasko, P. Grimm, R. Meier, and J. Malmgren Ten-year biochemical relapse-free survival after external beam radiation and brachytherapy for localized prostate cancer: the Seattle experience Int J Radiat Oncol Biol Phys 57 2003 944 952
7. A.A. Martinez, L.L. Kestin, and J.S. Stromberg Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial Int J Radiat Oncol Biol Phys 47 2000 343 352
8. J.C. Blasko, P.D. Grimm, J.E. Sylvester, and W. Cavanagh The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma Radiother Oncol 57 2000 273 278
9. R.G. Stock, and N.N. Stone Preliminary toxicity and prostate-specific antigen response of a phase I/II trial of neoadjuvant hormone therapy, Pd-103 brachytherapy, and three-dimensional conformal external beam irradiation in the treatment of advanced prostate cancer Brachytherapy 1 2002 2 10
10. L. Potters, Y. Cao, E. Calugaru, T. Torre, P. Fearn, and X. Wang A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 50 2001 605 614
11. B. Teh, M. Bastasch, W. Mai, E. Butler, and T.M. Wheeler Predictors of extracapsular extension and its radial distance in prostate cancer: implications for prostate IMRT, brachytherapy, and surgery Cancer J 9 2003 454 460
12. P.R.M. Thomas, M. Tefft, P.J. Compaan, P. Norkool, N.E. Breslow, and G.J. D'Angio Results of two radiation therapy randomizations in the third National Wilms' Tumor Study Cancer 68 1991 1703
13. G.S. Merrick, and W.M. Butler Modified uniform seed loading for prostate brachytherapy: rationale, design, and evaluation Tech Urol 6 2000 78 84
14. K. Wallner, G. Merrick, L. True, W. Cavanagh, C. Simpson, and W. Butler I-125 versus Pd-103 for low risk prostate cancer: morbidity outcomes from a prospective randomized multicenter trial Cancer J (Scientific American) 8 2002 67 73
15. K.R. Badiozamani, K.E. Wallner, W. Cavanagh, and J. Blasko Comparability of CT-based and TRUS-based prostate volumes Int J Radiat Oncol Biol Phys 43 1999 375 378
16. D. Schwartz, K. Billingsley, and K. Wallner Follow-up care for cancer: making the benefits equal the cost Oncology 14 2000 1493 1505
17. K. Tralins, and K. Wallner Follow-up costs after external beam irradiation for low risk prostate cancer Int J Radiat Oncol Biol Phys 44 1999 323 326
18. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Statist Assoc 53 1958 457 481
19. Sheretz T, Wallner K, Merrick G, et al. Factors predictive of rectal bleeding after Pd-103 and supplemental beam radiation for prostate cancer. Brachytherapy; vol. 3, pp 130-135, 2004.
20. M. Ghaly, K. Wallner, and G. Merrick The effect of supplemental beam radiation on prostate brachytherapy-related morbidity: morbidity outcomes from two prospective randomized multicenter trials Int J Radiat Oncol Biol Phys 55 2003 1288 1293
21. A.M. Syed, A. Puthawala, P. Austin, and J. Cherlow Temporary iridium-192 implant in the management of carcinoma of the prostate Cancer 69 1992 2515 2524
22. R.G. Stock, Y. Lo, M. Gaildon, and N.N. Stone Does prostate brachytherapy treat the seminal vesicles: a dose-volume histogram analysis of seminal vesicles in patients undergoing combined Pd-103 prostate implantation and external beam irradiation Int J Radiat Oncol Biol Phys 45 1999 385 389